Trial Profile
Phase I/II Study of AMG 531 in Patients With Advanced Malignancy Receiving Treatment With Carboplatin
Status:
Completed
Phase of Trial:
Phase I/II
Latest Information Update: 14 Jan 2020
Price :
$35
*
At a glance
- Drugs Romiplostim (Primary) ; Carboplatin; Doxorubicin; Ifosfamide
- Indications Thrombocytopenia
- Focus Adverse reactions
- 18 Nov 2014 New trial record